The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
about
Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System.Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional StudyEffective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionProton pump inhibitors and fracture: they impair bone quality and increase fall risk?Calcium, proton pump inhibitors, and fracture risk
P2860
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@en
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@nl
type
label
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@en
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@nl
prefLabel
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@en
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@nl
P2093
P2860
P1433
P1476
The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
@en
P2093
Alexandra Papaioannou
Arthur N Lau
Jonathan D Adachi
Matthew Wong-Pack
Michael Tomizza
P2860
P2888
P304
P356
10.1007/S12020-015-0576-Z
P577
2015-05-07T00:00:00Z